arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Astrana Health, Inc.

ASTH

$38.99 ▼ -0.68 (-1.71%) at close

14 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Astrana Health, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B

Dividend Yield —

Revenue Growth 56.4% ↗

Op. Margin 2.5% ↘

ROIC 2.7% ↘

FCF / Share $2.13 ↗

Trailing P/E 84.8x

Price / Book 2.5x

FCF Yield 5.5%

Debt / Equity 1.27

info Valuation on last close. End-of-day price, Nov 5, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.18B

↑ +56.4% —

Net Income Profit after all expenses

$22.49M

↓ -47.9% —

Operating Margin Operating profit as % of sales

2.5%

↓ -43.8% 35th

FCF / Share Free cash flow per share

$2.13

↑ +129.5% —

Long-Term Debt Long-term obligations

$990.90M

↑ +133.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓

Returns ↓

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Revenue Growth YoY (%)	56.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1028%)	46.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+834%)	21.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+324%)	47.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+857%)	12.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+152%)	22.6% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+352%)	7.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+57%)	45.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+818%)	16.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+230%)	594.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11791%)	761.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15137%)	31.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+523%)	—	—
EPS Growth YoY (%)	-49.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-30.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-40.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	62.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	153.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	24.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-67.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	119.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-47.9% Weak ↓ Weak Declining Year-over-year change in net income	-28.9% Weak ↓ Weak Declining Year-over-year change in net income	34.4% Excellent ↓ Excellent Declining Year-over-year change in net income	-38.8% Weak ↓ Weak Declining Year-over-year change in net income	95.1% Excellent ↑ Excellent Improving Year-over-year change in net income	168.2% Excellent ↑ Excellent Improving Year-over-year change in net income	30.3% Excellent ↓ Excellent Declining Year-over-year change in net income	-58.0% Weak ↑ Weak Improving Year-over-year change in net income	125.3% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-1197.2% Weak Weak Year-over-year change in net income	-360.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	129.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	8.8% Fair ↑ Fair Improving Year-over-year change in free cash flow	-35.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	12.9% Fair ↓ Fair Declining Year-over-year change in free cash flow	-5.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	238.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-50.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	-62.1% Weak Weak Year-over-year change in free cash flow	158.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	40.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	38.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	26.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	26.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.2% Good ↓ Good Declining Compound annual revenue growth over 3 years	24.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	22.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	127.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	311.6% Excellent Excellent Compound annual revenue growth over 3 years	328.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	35.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	29.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	21.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	26.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	20.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	73.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	155.9% Excellent Excellent Compound annual revenue growth over 5 years	166.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	-22.8% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-18.6% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	7.7% Fair ↓ Fair Declining Compound annual EPS growth over 3 years	34.6% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	72.4% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	1.0% Caution Caution Compound annual EPS growth over 3 years	-3.8% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Operating Margin (%) (%)	2.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	4.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-63%)	6.1% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-49%)	9.1% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-24%)	12.7% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+6%)	11.7% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	5.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-52%)	17.0% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+42%)	9.9% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-18%)	3.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-68%)	-16.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-237%)	-8.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	0.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-99%)	—
Effective Tax Rate (%) (%)	39.2% Weak → Weak Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	38.2% Weak → Weak Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	35.6% Weak ↓ Weak Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	47.2% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	36.6% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	31.4% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	0.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-91%)	2.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-73%)	4.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-45%)	3.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-51%)	9.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+19%)	5.5% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	2.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-69%)	2.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-74%)	7.2% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	3.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-53%)	-21.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-365%)	-14.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-276%)	-4.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-150%)	—
FCF Margin (%) (%)	3.3% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	2.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	2.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	5.2% Caution → Caution Stable Free cash flow as a percentage of revenue Optimal: > 10%	6.6% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.5% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	2.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	4.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	14.0% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.1% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-7.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-6.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	4.65x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.25x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.93x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.62x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.70x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Return on Invested Capital (%)	2.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.9% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	6.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	7.4% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	6.0% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	38.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	17.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	10.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	452.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	49.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-1.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	3.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	6.6% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	9.1% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	10.8% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	11.5% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	9.8% Fair → Fair Stable Operating profit relative to total assets Optimal: > 10%	4.4% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	17.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	7.2% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	3.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	0.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	2.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-81%)	6.1% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-60%)	9.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	8.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-44%)	16.2% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+8%)	11.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-24%)	7.4% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	6.0% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-60%)	16.1% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+8%)	13.1% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	—	109.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+628%)	50.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+235%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Debt to Equity (x)	1.27x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+82%)	0.60x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-15%)	0.42x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-40%)	0.37x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-46%)	0.40x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	0.70x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	1.21x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+73%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	-0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-123%)	—	—	—
Interest Coverage (x)	1.72x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	2.94x Caution ↓ Caution Declining Operating income divided by interest expense Optimal: > 5x	5.25x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	13.16x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	18.20x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	8.47x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	6.85x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	157.77x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	441.04x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	189.78x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-13.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	0.03x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$561.43M	$136.84M	$-34.87M	$-84.64M	$-50.18M	$36.74M	$128.98M	$-106.89M	$-99.75M	$-54.82M	$-9.07M	$-164.36K	$-397.10K	$-665.74K
Debt / EBITDA (x)	7.97x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	3.63x Caution ↑ Caution Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.53x Fair ↑ Fair Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.67x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.58x Good ↓ Good Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	2.33x Fair → Fair Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.54x Weak Weak Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.03x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Revenue per Share (USD)	$64.83	$42.74	$29.79	$25.44	$17.66	$18.81	$16.15	$15.81	$13.96	$12.40	—	—	—	—
Basic EPS, GAAP (USD)	$0.46	$0.91	$1.30	$1.00	$1.69	$1.04	$0.41	$0.33	$1.01	$0.46	—	—	—	—
Free Cash Flow per Share (USD)	$2.13	$0.93	$0.85	$1.32	$1.17	$1.23	$0.36	$0.74	$1.95	$0.75	—	—	—	—
Book Value per Share (USD)	$15.94	$14.87	$1.23K	$12.06	$10.37	$9.06	$5.33	$5.22	$4.95	$3.48	$-0.22	$-0.02	$-0.01	—
Tangible Book Value per Share (USD)	$-7.30	$3.66	$527.48	$4.37	$2.71	$0.13	$-4.18	$-2.66	$-4.13	$-4.96	$-0.89	$-0.02	$-0.01	—
Basic Weighted Avg Shares (shares)	49.08M	47.60M	46.55M	44.97M	43.83M	36.53M	34.71M	32.89M	25.53M	24.67M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Working Capital (USD)	$248.04M	$272.89M	$242.83M	$279.51M	$283.41M	$223.59M	$223.64M	$100.84M	$34.56M	$30.53M	$6.13M	$-266.04K	$1.10M	—
LT Debt (USD)	$990.90M	$425.30M	$258.94M	$203.39M	$182.92M	$230.21M	$232.17M	$0.00	—	—	—	—	—	—
Total Equity (USD)	$779.29M	$712.72M	$614.22M	$542.56M	$454.55M	$330.82M	$191.55M	$180.55M	$159.95M	$87.21M	$-1.27M	$-659.32K	$-311.31K	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Mar 31, 2016 10-K ↗	FY 2014 Jan 31, 2012 10-K ↗	FY 2013 Jan 31, 2011 10-K ↗	FY 2012 Jan 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$3.18B	$2.03B	$1.39B	$1.14B	$773.91M	$687.18M	$560.62M	$519.91M	$356.36M	$305.93M	$44.05M	$5.11M	$3.90M	—
Depreciation Expense (USD)	$45.75M	$27.93M	$17.75M	$17.54M	$17.52M	$18.35M	$18.75M	$19.30M	$19.08M	$18.11M	$351.40K	$12.59K	$11.20K	—
Net Income, GAAP (USD)	$22.49M	$43.15M	$60.72M	$45.17M	$73.86M	$37.87M	$14.12M	$10.84M	$25.80M	$11.45M	$-9.34M	$-720.35K	$-156.33K	—
Operating Cash Flow (USD)	$114.60M	$52.20M	$68.23M	$82.13M	$70.33M	$46.16M	$13.67M	$25.50M	$51.83M	$21.91M	—	$-385.45K	$-245.03K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 55 quarters

Astrana Health, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ASTH with peers